Travel-related hepatitis E: a two-decade GeoSentinel analysis
Open Access
- 12 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 27 (7)
Abstract
Background: Hepatitis E virus (HEV) is widely distributed worldwide and is endemic in developing countries. Travel-related HEV infection has been reported at national levels, but global data are missing. Moreover, the global availability of HEV diagnostic testing has not been explored so far. The aim of this study is to describe the epidemiology of HEV infections in returning travellers and availability of HEV diagnostic testing in the GeoSentinel surveillance network. Methods: This was a multicentre retrospective cross-sectional study. All confirmed and probable HEV travel-related infections reported in the GeoSentinel Network between 1999 and 2018 were evaluated. GeoSentinel sites were asked to complete a survey in 2018 to assess the availability and accessibility of HEV diagnostic procedures (i.e. serology and molecular tests) throughout the study period. Results: Overall, 165 travel-related HEV infections were reported, mainly since 2010 (60%) and in tourists (50%). Travellers were exposed to hepatitis E in 27 countries; most travellers (62%) were exposed to HEV in South Asia. One patient was pregnant at the time of HEV infection and 14 had a concomitant gastrointestinal infection. No deaths were reported. In the 51% of patients with information available, there was no pre-travel consultation. Among 44 GeoSentinel sites that responded to the survey, 73% have access to HEV serology at a local level, while 55% could perform (at a local or central level) molecular diagnostics. Conclusion: Reported access to HEV diagnostic testing is suboptimal among sites that responded to the survey; this could negatively affect diagnosing HEV. Pre-travel consultations before travel to South Asia and other low-income and high-prevalence areas with a focus on food and water precautions could be helpful in preventing hepatitis E infection. Improved HEV diagnostic capacity should be implemented to prevent and correctly diagnose travel-related HEV infection.Keywords
Funding Information
- International Society of Travel Medicine (U50 C1000359)
This publication has 25 references indexed in Scilit:
- Fulminant hepatic failure from hepatitis E in a non-pregnant female traveller: Table 1.Journal of Travel Medicine, 2016
- Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011.2013
- Acute Hepatitis in Israeli TravelersJournal of Travel Medicine, 2013
- Hepatitis EThe Lancet, 2012
- The incidence of hepatitis E virus infection in the general population of the USAEpidemiology and Infection, 2010
- Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trialThe Lancet, 2010
- Epidemiology and Risk Factors of Incident Hepatitis E Virus Infections in Rural BangladeshAmerican Journal of Epidemiology, 2010
- Hepatitis E in the south west of France in individuals who have never visited an endemic areaJournal of Medical Virology, 2004
- Rates of Hepatitis E Virus Infection and Disease among Adolescents and Adults in Kathmandu, NepalThe Journal of Infectious Diseases, 1997
- Evidence for a Virus in Non-A, Non-B Hepatitis Transmitted via the Fecal-Oral RouteIntervirology, 1983